NCT01814813: Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery |
|
|
| Terminated | 2 | 90 | US | HSPPC-96, bevacizumab | Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI), Agenus Inc. | Recurrent Glioblastoma, Recurrent Adult Brain Tumor, Gliosarcoma | 04/17 | 05/23 | | |